Summary Of Loading Off Bottom - As At Close June 8.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
141
Summary Of Loading Off Bottom - As At Close June 8.

Bought at 1.4001 > 1.6000 [.0008]

Jan 15: 1,750

Total: 1,750

Bought at 1.2001 > 1.4000 [.0007]

Jan 15: 1,247

Total: 1,247

Bought at 1.0001 > 1.2000 [.0006]

Jan 15: 3,179

Total: 3,179

Bought at .8001 > 1.000 [.0005]

Jan 15: 2,484
Jan 16: 1,200
Jan 17: 1,330
Jan 18: 50

Total: 5,064

Bought at .6001 > .8000 [.0004]

Jan 15: 8,027
Jan 16: 2,411
Jan 17: 13,000
Jan 18: 235
Jan 22: 1,000

Total: 24,673

Bought at .4000 > .6000 [.0003]

Jan 18: 88,566
Jan 22: 16,500
Jan 23: 1,330
Jan 24: 300
Jan 25: 2,040
Jan 29: 6,319
Jan 30: 14,895 [all above .4200 - most around .4400]
Jan 31: 5,877
Feb 1: 8,100
Feb 4: 626
Feb 6: 230
Feb 7: 18,368
Feb 15: 674
Feb 19: 1,926 [all at .4200 / .4300]
Feb 20: 4,127 [all at .4425 > .4500]
Feb 22: 3,370 [.4500 / .4600 / .4999 / 2000 at .5267]
Feb 25: 25,902 [16,859 .4600 > .5000 / 5,660 .5200 > .5985]
Feb 26: 21,078 [18,778 .4750 > .4975 / 2,300 .5050 > .5500]
Feb 27: 10,350 [6,200 .4500 > .4780 / 1,250 .5100 > 5775]
Feb 28: 18,050 [11,500 .4600 > .4999 / 950 .5000 > .5999]
Mar 1: 6,981 [all .4060 / .4100 / .4600]
Mar 4: 200 [all .4900 / .5100]
Mar 5: 80 [all .5100]
Mar 6: 10,522 [7,800 - 73% .5100]
Mar 7: 200 [50% .4700 / 50% .5100]
Mar 8: 23,820 [19,900 .4450 > .4700 / 3,920 .5100]
Mar 11: 3,818 [.4000 / .4500 / .5000]
Mar 12: 7,390 [1,800 .4500 / 5,410 .5000/.5100]
Mar 13: 78,449 [0 < .4500 / 46,898 .4900 > .5800 / 10,300 .5500 > .5800]
Mar 14: 2,420 [.4950 / .5100 / .5200]
Mar 15: 11,638 [.4900 / .5399 / .5400]
Mar 18: 2,848 [1,000 .5000 / 1,000 .5100 / 650 .5300]
Mar 19: 1,155 [.5205/.5524]
Mar 20: 902 [.5350/.5400]
Mar 21: 6,200 [.5400/.5790]
Mar 22: 14,918 [5,580 .5100 > .5699]
Mar 25: 9,645 [.5100 > .5979 / 8,074 .5499 / .5500]
Mar 26: 6,975 [4,000 .4850 > .4979 / 2,825 .5017 > .5970]
Mar 27: 2,959 [1,000 .5500 / 1,303 .5950]
Mar 28: 10,384 [3,850 .5500 > .5620 / 4,384 .5900 > .5950]
Mar 29: 4,788 [4,200 .5600 > .5700]
Apr 1: 20,085 [1,169 .5474 > .5789 / 5,250 .5800 / 10,200 .5900 > .5999]
Apr 2: 5,744 [2,150 .5200 > .5499 / 2,698 .5500 > .5900]
Apr 3: 20,479 [5,045 .5300 > .5500 / 7,533 .5600 > .5790 / 5,499 .5999]
Apr 4: 15,848 [7,933 .5000 / 4,915 .5100 > .5400 / 3000 .5600]
Apr 5: 1,799 [all .5000 > .5290]
Apr 8: 6,740 [ all .5000 > .5700]
Apr 9: 1,712 [.5000 / .5400 / 1,000 .5700]
Apr 10: 20,802 [12,851, .5000 / 7,900 .51525 / .5250 / .5300]
Apr 11: 3,953 [all .5250]
Apr 12: 5,255 [1200 .5200 - remainder of ask retreated to .5850]
Apr 15: 5,296 [3,860 .5200]
Apr 16: 4,526 [3,700 .5100/.5250]
Apr 17: 15,970 [ 1,734 .5000 / 2,000 .5100 / 8,070 .5200 > .5400]
Apr 18: 2,400 [400 .5400/.5500 / 1,000 .5850]
Apr 22: 1,815 [1,010 .5300]
Apr 23: 5,711 [4,071 .4750 / 1,640 .5000 > .5300]
Apr 24: 3,678 [3,025 .4800 > .5000 hidden bid / 600 .5150 > .5400]
Apr 25: 875 [.4800 > .5100]
Apr 26: 8,333 [8,265 .5100]
Apr 29: 14,119 [.4500 hidden bid > .5700]
Apr 30: 3,080 [.4500 hidden bid > .5100]
May 1: 308 [.5100 > .5148]
May 2: 1,704 [hidden bid .4500 > .5350]
May 3: 323 [hidden bid .4500 > .5300]
May 6: 675 [hidden bid .4500]
May 7: 2,082 [hidden bid .4500 / 100 .5100 / 1,772 .5288 > .5300]
May 8: 2,036 [hidden bid .4500 / 1,981 .5100 > .5250]
May 9: 625 [hidden bid .4500 / 250 .5139 > .5200]
May 10: 14,022 [visible bid .4500 then .4600 > .5200]
May 13: 968 [hidden bid .4500 / .5100 > .5200]
May 14: 3,737 [hidden bid .4500 / 2,119 .5100 > .5200]
May 15: 1,845 [hidden bid .5000 / .5100]
May 16: 3,984 [hidden bid .5000 / .5150]
May 17: 250 [hidden bid .5000]
May 20: 924 [hidden bid .4550 / 823 .5100
May 22: 41 [hidden bid .4550]
May 23: 279 [hidden bid .4550]
May 24: 4,312 [hidden bid .4550 / 555 .5100]
May 28: 700 [hidden bid .4550 / 100 .5100]
May 29: 298 [hidden bid .4550 / 100 .5100]
May 30: 3,723 [hidden bid .4550 / 200 .5100]
May 31: 301 [200 hidden bid .5000 / 100 .5100]
Jun 4: 50 [hidden bid .4800]
Jun 7: 40,950 [almost all at hidden bid .4977l]
Jun 8: 72 [hidden bid .4977]

Total: 668,426

Bought at .2310 > .3999:

Jan 15: 10,418 [all at .0380 - .0002 equivalent]
Jan 18: 22,269
Jan 23: 16,052 [mostly .0370/.0380/.3999]
Jan 24: 18,089 [mostly .0380/.0399]
Jan 25: 17,456 [mostly .0370/.0380]
Jan 28: 23,054 [mostly .0360/.0370/.0390]
Jan 29: 4,189 [mostly at .3900]
Jan 31: 3,001 [all around .3700]
Feb 1: 230 [at .0380]
Feb 4: 4,090 [all at .3800/.3825/.3900]
Feb 5: 6,334 [all at .3800/.3801/.3825]
Feb 6: 222 [all at .3800/.3801/.3813]
Feb 7: 3,144 [all at .3800/.3850]
Feb 8: 71,730 [mostly at .3400/.3800]
Feb 11: 19,719 [ask was .3300/.3400]
Feb 12: 763 [paint downs under ask .3300]
Feb 13: 13,675 [mostly at .3300 >.3425 - then none available < .4000]
Feb 14: 1,146 [all at .3350 > .4000 - then none available < .4200]
Feb 15: 6,608 [almost all at .3900 - then none available <.4300]
Feb 19: 7,356 [all at .3500 or 3837/.3975]
Feb 20: 1,200 [only 200/250/500 at .3025 > .3200]
Feb 21: 990 [only 830/55/105 at .3025 > .3100]
Feb 22: 4,567 [1 at .3100 open p/d - then .3250/.3420/.3480/.3500/.3550]
Mar 1: 5,500 [all .3900 / .3905]
Mar 4: 277 [all .3900]
Mar 5: 186 [all .3900]
Mar 6: 113 [.3900]
Mar 11: 1,125 [paints below extant .3900 bid]
Mar 12: 3,128 [paints below extant .3900 bid]

Total: 239,237

Assume following worst case prior from loading on January 14:

Bought at 1.000 [.0005]: 10,000 [20M] [estimate]

Bought at .8000 [.0004]: 23,000 [46M] [estimate]

Bought at .6000 [.0003]: 50,000 [100M] [estimate]

Bought at .4000 [.0002] 200,000 [400M] [estimate]

Total: 283,000 [566M] [precise]







Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading